A scalable and robust cationic lipid/polymer hybrid nanoparticle platform for mRNA delivery.

Meyer, Randall A; Hussmann, G Patrick; Peterson, Norman C; Santos, Jose Luis; Tuesca, Anthony D

Meyer, Randall A; Hussmann, G Patrick; Peterson, Norman C; Santos, Jose Luis; Tuesca, Anthony D.

Afiliación

Meyer RA; BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States.
Hussmann GP; BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States.
Peterson NC; BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States.
Santos JL; BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States. Electronic address: luis.santos1@astrazeneca.com.
Tuesca AD; BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States. Electronic address: anthony.tuesca@astrazeneca.com.

Int J Pharm ; 611: 121314, 2022 Jan 05.

Article en En | MEDLINE | ID: mdl-34838950

Asunto(s)

Nanopartículas; Polímeros; Cationes; Microfluídica; ARN Mensajero

Palabras clave

Drug delivery; Lipids; Microfluidics; Nanoparticles; Polymers; mRNA delivery

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Polímeros / Nanopartículas Idioma: En Revista: Int J Pharm Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google